Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00116623 · ClinicalTrials.gov registry record · Phase 4
Magnesium Sulfate Versus Indomethacin for Preterm Labor
A Phase 4 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00116623: Clinical Trial Phase 4 study, sponsored by University of Pennsylvania.
NCT00116623 is a Phase 4 study that was terminated before completion, run by University of Pennsylvania. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00116623, a Phase 4 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to investigate the efficacy of Indomethacin compared to Magnesium Sulfate (MgSO4) in reducing neonatal morbidity through a prospective double blind randomized clinical trial. The specific aim of the project is to test the hypothesis that Indomethacin, compared to MgSO4, will decrease the proportion of neonates diagnosed with major complications or death.
Interventions
- DRUG Indomethacin
- DRUG Magnesium sulfate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-02 |
| Est. Completion | 2006-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00116623
The ClinicalTrials.gov registry entry for NCT00116623 describes a study currently listed as terminated, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indomethacin is the first listed.
NCT00116623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00116623 about?
NCT00116623 is a clinical study titled "Magnesium Sulfate Versus Indomethacin for Preterm Labor". The purpose of this study is to investigate the efficacy of Indomethacin compared to Magnesium Sulfate (MgSO4) in reducing neonatal morbidity through a prospective double blind randomized clinical trial. The specific aim of the project is to test the hypothesis that Indomethacin, compared to MgSO4, ...
What is the current status of trial NCT00116623?
This trial is currently terminated. It is a Phase 4 study. The study started on 2003-02. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00116623?
The interventions under investigation include: Indomethacin (DRUG), Magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT00116623?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.